Stroke and alzheimer disease: Fellow travelers or partners in crime?

Archives of Neurology

Volumn 68, Issue 6, 2011, Pages 797-798

  Hachinski, Vladimir ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; BRAIN INFARCTION; BRAIN ISCHEMIA; COGNITIVE DEFECT; DISEASE COURSE; EXECUTIVE FUNCTION; HUMAN; HYPERTENSION; IMMOBILIZATION; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NOTE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

ALZHEIMER DISEASE; COGNITION DISORDERS; COMORBIDITY; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; RISK FACTORS; STROKE;

EID: 79958732576     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.118     Document Type: Note

References (6)

1. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000;57(6):808-813. (Pubitemid 30397182)
2. Jin YP, Di Legge S, Ostbye T, Feightner JW, Hachinski V. The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement. 2006;2(3):171-178. (Pubitemid 43843090)
3. Whitehead SN, Cheng G, Hachinski VC, Cechetto DF. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke. 2007;38(12):3245-3250. (Pubitemid 350175744)
4. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220-2241. (Pubitemid 44337162)
5. Oveisgharan S, Hachinski V. Hypertension, executive dysfunction, and progression to dementia: the Canadian Study of Health and Aging. Arch Neurol. 2010;67(2):187-192.
6. Hachinski V. Shifts in thinking about dementia. JAMA. 2008;300(18):2172-2173.